^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Poly-ICLC matured DC adjuvanted NY-ESO-1/Melan-A-MART-1 peptide vaccine

    i
    Associations
    News

    Trials

    Company:
    Icahn School of Medicine at Mount Sinai
    Drug class:
    Immunostimulant
    Related drugs:
    Associations
    News

    Trials

    Apply
    A Comparison of Matured Dendritic Cells and Montanide® in Study Subjects With High Risk of Melanoma Recurrence (NCT02334735)
    Phase 2
    Nina Bhardwaj
    Completed
    Last update posted :
    09/15/2022
    Initiation :
    07/01/2015
    Primary completion :
    07/15/2020
    Completion :
    07/15/2020
    CD8 • CTAG1B • CD4
    |
    Hiltonol (poly-ICLC) • Poly-ICLC matured DC adjuvanted NY-ESO-1/Melan-A-MART-1 peptide vaccine